Skip to main content

Table 1 Univariate analyses of risk factors associated with DVT of lower extremity following isolated patella fracture (continued)

From: Incidence and risk factors for deep venous thrombosis of lower extremity after surgical treatment of isolated patella fractures

Variables

Non-DVT (n = 687) (number (%))

DVT (n = 29) (number (%))

p

Gender (male)

406 (59.1)

19 (65.5)

0.491

Age (year)

51.0 ± 14.5

59.6 ± 14.6

0.002

 18–44

228 (33.2)

6 (20.7)

0.000

 45–64

338 (49.2)

9 (31.0)

 

 65 or older

121 (17.6)

14 (48.3)

 

BMI (kg/m2)

  

0.937

 18.5–23.9

412 (60.0)

18 (62.1)

 

 < 18.5

24 (3.5)

0 (0)

 

 24.0–27.9

185 (26.9)

8 (27.6)

 

 ≥ 28.0

66 (9.6)

3 (10.3)

 

Cigarette smoking

90 (13.1)

4 (13.8)

0.784

Alcohol consumption

63 (9.2)

6 (20.7)

0.051

Diabetes mellitus

71 (10.3)

6 (20.7)

0.115

Hypertension

142 (20.7)

12 (41.4)

0.008

Ischemic heart disease

41 (6.0)

3 (10.3)

0.414

Arrhythmia

29 (4.2)

7 (24.1)

0.000

Chronic lung diseases

6 (0.9)

2 (6.9)

0.038

History of cerebral infarction

25 (3.6)

2 (6.9)

0.300

History of any surgery

116 (16.9)

8 (27.6)

0.136

Injury mechanism (high energy)

90 (13.1)

3 (10.3)

0.665

Fracture type (comminuted)

69 (10.0)

6 (20.7)

0.110

Preoperative stay

3.0 ± 1.8

4.8 ± 3.2

0.004

Total hospital stay

11.9 ± 6.6

13.4 ± 6.9

0.238

Anesthesia (general)

32 (4.7)

3 (10.3)

0.164

ASA class

  

0.174

 III and above

33 (4.8)

3 (10.3)

 

 I and II

654 (95.2)

26 (89.7)

 

Intra-operative blood loss

98.5 ± 42.8

126.9 ± 58.4

0.015

Surgical duration

95.5 ± 30.3

139.3 ± 37.8

0.000

Tourniquet use (yes)

553 (80.5)

26 (89.7)

0.219

TP (< 60 g/L)

327 (47.6)

11 (37.9)

0.307

ALB (< 35 g/L)

202 (29.4)

5 (17.2)

0.157

FBG (> 6.1 mmol/L)

209 (30.4)

7 (24.1)

0.470

TC (> 5.2 mmol/L)

53 (7.7)

3 (10.3)

0.489

TG (> 1.7 mmol/L)

149 (21.7)

5 (17.2)

0.568

LDL-C (> 3.37 mmol/L)

180 (26.2)

13 (44.8)

0.027

VLDL (> 0.78 mmol/L)

147 (21.4)

5 (17.2)

0.592

HDL-C (< 1.1 mmol/L)

189 (27.5)

7 (24.1)

0.690

WBC (> 10 × 109/L)

141 (20.5)

5 (17.2)

0.667

NEUT (> 6.3 × 109/L)

248 (36.1)

11 (37.9)

0.084

LYM (< 1.1 × 109/L)

108 (15.7)

5 (17.2)

0.796

RBC (<lower limit)

146 (21.3)

9 (31.0)

0.210

HGB (<lower limit)

148 (21.5)

10 (34.5)

0.100

HCT (<lower limit)

121 (17.6)

10 (34.5)

0.021

PLT (> 300 × 109/L)

42 (6.1)

6 (20.7)

0.010

PDW (> 18.1%)

13 (1.9)

1 (3.4)

0.442

RDW (> 16.5%)

6 (0.9)

0 (0)

0.780

D-dimer (> 0.3 mg/L)

299 (43.5)

20 (69.0)

0.007

  1. DVT deep venous thrombosis; BMI body mass index; ASA American Society of Anesthesiologists; RBC red blood cell, reference range: females, 3.5–5.0 × 1012/L, males, 4.0–5.5×1012/L; HGB hemoglobin, reference range: females, 110–150 g/L, males, 120–160 g/L; FBG fasting blood glucose; HCT hematocrit, 40–50%; WBC white blood cell; NEUT neutrophile; LYM lymphocyte; PLT platelet, 100–300 × 109/L; TP total protein; ALB albumin; RDW red cell distribution width; PDW platelet distribution width; TC total cholesterol; TG triglyceride; LDL-C low-density lipoprotein cholesterol; HDL-C high-density lipoprotein cholesterol; VLDL very low-density lipoprotein